A Mendelian randomization study for drug repurposing reveals bezafibrate and fenofibric acid as potential osteoporosis treatments.
Frontiers in pharmacology（2023）
Abstract
Background:Methods:Results:HMGCRNPC1L1PCSK9PPARGPPARGpp-5ppPPARGConclusion:
MoreTranslated text
Key words
osteoporosis,drug repurposing,fenofibric acid,mendelian randomization study
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined